SELLAS Life Sciences Group, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -101.7% | -101.7% | -78.8% |
| FY2022 | -851.4% | -851.4% | -197.2% |
| FY2023 | 468.2% | 468.2% | -600.4% |
| FY2024 | -326.3% | -326.3% | -158.9% |
| FY2025 | -37.9% | -37.9% | -34.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -101.7% | -101.7% | -78.8% |
| FY2022 | -851.4% | -851.4% | -197.2% |
| FY2023 | 468.2% | 468.2% | -600.4% |
| FY2024 | -326.3% | -326.3% | -158.9% |
| FY2025 | -37.9% | -37.9% | -34.3% |